X-STOP Spacer
How it works
Clinical results
Frequently asked questions
Preoperative considerations and postoperative care
Payment authorization process
Reimbursement Resource Center
Important safety information
Understanding reimbursement for the X-STOP® IPD® System is key to giving patients access to care. Our team of reimbursement professionals is dedicated to assisting healthcare providers and consumers navigate the complex reimbursement environment typical in today's healthcare industry. We are pleased to provide the following information to enhance your understanding of coverage policies, coding, and payments for the X-STOP IPD System.
Sample operative report and letters FAQs and reimbursement updates
Sample Operative Report Sample Letter of Pre-Authorization and Medical Necessity Sample Appeal Letter Prior Authorization/Pre-Determination Process and Appeals Guide FDA Letter
The Health Care Policy and Reimbursement Team is committed to providing you with current information regarding applicable coding and reimbursement for our products. These notices provide you with an update concerning recent developments in reimbursement for the X-STOP IPD System. The following documents will assist you with the coding and reimbursement process.
Hospital Outpatient Prospective Payment System (HOPPS) for 2008 X-STOP IPD Procedure Hospital Inpatient Prospective Payment System (HIPPS) effective October 1, 2007 X-STOP IPD Procedure
Contact a member of the Health Care Policy and Reimbursement Team Get your free X-STOP Spacer information kit
Printer friendly E-mail to a friend Bookmark
This treatment is prescribed by your doctor. It is not for everyone. Please talk with your doctor and see if it is right for you. Your doctor should discuss all potential benefits and risks with you. Although many patients benefit from the use of this treatment, approximately half of the patients who received the X-STOP device in the 2-year study experienced a degree of pain relief and ability to increase their activity levels that was sufficient to be considered a successful outcome at 2 years after surgery. This compares with the control group treated with non-surgical care that had a 6% successful outcome treatment success rate.15